Menopausal Hormone Therapy May Boost GLP-1 Weight Loss

Coverage, in order

1. 15d ago
   
   first Everyday Health mainstream explainer

   Are GLP-1 Users Satisfied With Their Weight Loss?

   People Often Have to Stop and Restart the Medication Ozempic (semaglutide) was the most commonly used medication, the survey found. Most current GLP-1 users had been taking the medication for six months or longer. But 61 percent had stopped and started the medication at least once. Overall, among…

2. 15d ago
   
   MedPage Today indie observational

   Menopausal Hormone Therapy May Boost GLP-1 Weight Loss

   (MedPage Today) -- Menopausal women taking hormone therapy in addition to a GLP-1 medication may see greater and sustained weight loss, a retrospective cohort study suggested. Women taking semaglutide (Wegovy) and menopausal hormone therapy had...

3. 15d ago
   
   Healio indie

   Hormone replacement therapy could increase menopausal migraines

   Hormone replacement therapy, or HRT, may lead to longer, more frequent migraines, according to research presented at The Menopause Society’s annual meeting. “Migraines can have a significant impact on quality of life, particularly during the menopause transition when many women experience changes…

4. 15d ago
   
   Healthline mainstream

   Hormone Therapy May Boost Weight Loss on Wegovy, But Not as Much on Zepbound

   New research shows that using hormone therapy with a GLP-1 during menopause may lead to greater weight loss. Tatsiana Volkava · Moment/Getty A study presented at the 2026 Annual Meeting of The Menopause Society found that women using menopause hormone therapy (MHT) alongside semaglutide (Ozempic…

5. 15d ago
   
   Healthline mainstream

   Switching from GLP-1 Injections to Wegovy Pill Shows Additional Weight Loss of 4.1%

   Recent research shows people who switch to the Wegovy pill from a GLP-1 injection can lose additional weight. PixelsEffect · E+/Getty People with overweight or obesity who switched from an injectable GLP-1 weight loss medication to the Wegovy (semaglutide) pill lost an average of 4.1% of their body…

6. 15d ago
   
   Healthline mainstream

   Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages

   A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Healthline/Photo by Eli Lilly A new analysis of previous studies found that orforglipron promoted weight loss in women regardless of their…

7. 15d ago
   
   Healthline mainstream

   Microdosing GLP-1s Like Wegovy, Zepbound May Still Lead to Weight Loss

   Research shows that microdosing GLP-1 medications may still lead to weight loss. Tatsiana Volkava · Moment/Getty Recent research suggests that people may still lose weight while staying on the lowest starting doses of GLP-1 medications, such as Wegovy or Zepbound, for longer periods. After one…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.